A survival analysis of the prognostic information of 60 bladder cancer patients using immunohistochemical results showed that the higher the expression of ABCF1, the worse the prognosis of the patient was (P = 0.03; Fig. 8C) (Additional file 2). This evidence concerns the gene ABCF1 and urinary bladder carcinoma.